Hello, Share Swashers. As the page views show, interest in the Avacta (AVCT) saga remains very high among the elite group of Shareprophets subscribers. Judging by the bulletin boards on some lesser websites, interest is also keen if often laughably optimistic. Allow me to give you an update on this most volatile of virus-related plays...
I see that Barry “The Tit” Gibb at broker Turner Pope has produced a gushing note on Avacta (AVCT ) today. Maybe that will help a few more Turner Pope clients to flip the stock they got in the recent 120p placing. Or maybe The Tit just wants a distraction from wittering an about Tomco (TOM), shares in which remain suspended although it has, today, been forced to admit that its RNS that accompanied a Turner Pope placing yesterday, contained a massive porky. Back to Avacta, when your cheerleader in chief is “The Tit” you know it is right to be bearish.
Hello Share Keepers. As wise Shareprophets contributor Periotlunaire rightly observes: trading shares in Avacta Group (AVCT) is a poker game. While Uncle Tom says we should sell this small medical pioneer because the company is grossly overvalued and the current share price won’t last much longer...
When you have just raised £48 million of dumb money you cannot turn around a week later and scream SUCKERS! No. You have to pretend that the reason your shares raced away and that the fools piled in greedily is still valid. But it is not, and at some stage, Avacta (AVCT) will have to admit as much.
Hello, Share Isolators. The question of what to do with Avacta (AVCT) shares continues to be even thornier. The price exceeded 200p a week or so ago, then began a double-digit daily decline. Towards last week’s end it perked up again and at the time of writing is 157p...
Hello, Share Tasters. Once again, I’m in the unenviable position of holding loads of shares in a company that Tom finds to be overvalued. When this happens I tend to dump most of the shares, as Tom has a surgical mind and I’m an instinct man. Yes, it may be an instinct based on centuries of daily share dealing experience but you have to consider what cold analysts like Tom think too. I hold shares in Avacta (AVCT)...
A week ago, Malcolm Stacey could have sold his shares in Avacta (AVCT) at more than 200p each. In fact I think the old trading genius might just have done that. Then the company started “sounding out” investors about a fund raise and, not that anyone in London ever breaks insider dealing laws so this is a total coincidence, the shares started tumbling fast. As I write they are off by 5p at 132-5p as it has announced am up to £45 million fund raise at 120p. I don’t blame it.
Hello, Share Fielders. A few weeks ago, Uncle Tom did the sums and pronounced that the valuation of Avacta (AVCT) after some spectacular share rises was ‘bonkers.’ If it was bonkers then, it must be mega-bonkers now as the price has risen relentlessly whether the action is justified or not and is now above 200p. When I first commended it to your researches it was less than 20p, but can this potential bubble stay unpricked for a bit longer?...
Hello, Share Shifters. I find myself on the horns of a horrible dilemma. And once again, it’s due to Uncle Tom Winnifrith. He has written a couple of immaculately researched pieces on this legendary website warning that a company in my portfolio is overvalued. Indeed, he says the valuation of medical pioneer Avacta (AVCT) is 'bonkers'...
Hello, Share Takers. Uncle Tom has described the valuation of Avacta Group (AVCT) as ‘bonkers’. With his diamond record, few will quarrel with that. Therefore, long-term players should probably avoid this stock. But what about opportunistic momentum investors?...
Hello Share Plodders. It’s all beginning to look more optimistic don’t you think? A human trial for a vaccine started at Oxford University. Many more tests being rolled out. The number of sad deaths down. More countries easing themselves out of lockdown. New research shows the virus can't stand summer temperatures. So many good signs, that you may be surprised shares are still languishing.
Hello, Share Spanners. A look at the daily trades for a recent recommendation of mine has recently shown quite a bit of profit-taking going on. But I’m hanging onto my shares because I think the upward action is far from over. And indeed Avacta (AVCT) is up by another 25% on its latest news...
Hello, Share Scudders. It’s worth an update on a successful recent tip on this venerable website. I refer to Avacta Group (AVCT). The share was well below 20p earlier this year. It’s up as I write to above 60p and in my humble opinion could have further to go...
Hello, Share Trundlers. A few days ago, I suggested a small medical pioneer might see a share rise because of its association with a substitute for human antibodies. This proved to be a correct assumption as the share has doubled since then.
Hello, Share Scramblers. My series of predictions of shares which may rise faster than others once the outbreak reaches its peak, today features Avacta (AVCT). This is one of my favourite biotech companies, though the share price hasn’t exactly sparkled over the years. So why might this share be of interest once it's safe to buy shares again?...
Hello, Share Breakers. It’s rare that I return to the same share shortly after a commendation. But for this company, I’m coming back a third time in fairly short order...
Hello, Share Speakers. If you’d acted on my Avacta (AVCT) commendation yesterday you’d be up by nearly 20% already. But I still think there’s a chance to make some more on this interesting share. What I didn’t have time to analyse yesterday was the latest trading update – which makes jolly reading...
Hello Share People. It’s all looking chipper for medical pioneer Avacta (AVCT). When Tom interviewed me fairly recently for his scintillating radio podcast, I gave this company the dubious award as my favourite penny share. And so far, luckily, I am proving right. The latest news is pretty exciting and, as I write, has propelled the share up by 15%...
